Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 196

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

SARS-CoV-2 Mutations and their Viral Variants

Open access
Cosar, Begum, Karagulleoglu, Zeynep Yagmur, Unal, Sinan, Ince, Ahmet Turan, Uncuoglu, Dilruba Beyza, Tuncer, Gizem, Kilinc, Bugrahan Regaip, Ozkan, Yunus Emre, Ozkoc, Hikmet Ceyda, Demir, Ibrahim Naki, Eker, Ali, Karagoz, Feyzanur, Simsek, Said Yasin, Yasar, Bunyamin, Pala, Mehmetcan, Demir, Aysegul, Atak, Irem Naz, Mendi, Aysegul Hanife, Bengi, Vahdi Umut, Cengiz Seval, Guldane, Gunes Altuntas, Evrim, Kilic, Pelin, Demir-Dora, Devrim · 2022 · Cytokine & Growth Factor Reviews

Abstract

Mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occur spontaneously during replication. Thousands of mutations have accumulated and continue to since the emergence of the virus. As novel mutations continue appearing at the scene, naturally, new variants are increasingly observed. Since the first occurrence of the SARS-CoV-2 infection, a wide variety of drug compounds affecting the binding sites of the virus have begun to be studied. As the drug and vaccine trials are continuing, it is of utmost importance to take into consideration the SARS-CoV-2 mutations and their respective frequencies since these data could lead the way to multi-drug combinations. The lack of effective therapeutic and preventive strategies against human coronaviruses (hCoVs) necessitates research that is of interest to the clinical applications. The reason why the mutations in glycoprotein S lead to vaccine escape is related to the location of the mutation and the affinity of the protein. At the same time, it can be said that variations should occur in areas such as the receptor-binding domain (RBD), and vaccines and antiviral drugs should be formulated by targeting more than one viral protein. In this review, a literature survey in the scope of the increasing SARS-CoV-2 mutations and the viral variations is conducted. In the light of current knowledge, the various disguises of the mutant SARS-CoV-2 forms and their apparent differences from the original strain are examined as they could possibly aid in finding the most appropriate therapeutic approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cytogfr.2021.06.001

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 196

Metadata

Authors
Cosar, B., Karagulleoglu, Z. Y., Unal, S., Ince, A. T., Uncuoglu, D. B., Tuncer, G., Kilinc, B. R., Ozkan, Y. E., Ozkoc, H. C., Demir, I. N., Eker, A., Karagoz, F., Simsek, S. Y., Yasar, B., Pala, M., Demir, A., Atak, I. N., Mendi, A. H., Bengi, V. U., Cengiz Seval, G., Gunes Altuntas, E., Kilic, P., & Demir-Dora, D.
Venue
Cytokine & Growth Factor Reviews
Publisher
Elsevier BV
Published
2022-02
Volume
63
Pages
10-22
ISSN
1359-6101 (ISSN-L)
OpenAlex
W3181135909
Cited by
196
References
34
FWCI
5.77
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SARS-CoV-2 Mutations and their Viral Variants. https://app.cochat.ai/papers/10.1016/j.cytogfr.2021.06.001
The paper
Cosar, B., Karagulleoglu, Z. Y., Unal, S., Ince, A. T., Uncuoglu, D. B., Tuncer, G., Kilinc, B. R., Ozkan, Y. E., Ozkoc, H. C., Demir, I. N., Eker, A., Karagoz, F., Simsek, S. Y., Yasar, B., Pala, M., Demir, A., Atak, I. N., Mendi, A. H., Bengi, V. U., . . . Demir-Dora, D. (2022). SARS-CoV-2 Mutations and their Viral Variants. Cytokine & Growth Factor Reviews. https://doi.org/10.1016/j.cytogfr.2021.06.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.